First, no biopsy study of TePs has yet shown any primary abnormality of muscle, tendon, or other soft tissue that is unique and specific to patients with FMS.17,18 Second, an intriguing finding came from studies that attempted to com- pare pain thresholds over TeP sites in FMS with normal control points on the same subjects
doi: 10.1007/s12035-023-03713-0, 24
You do not have to cancel another birthday party
The test reveals your genetic predisposition to GLP-1 and GIP pathway responsiveness, helping determine whether dose escalation, a switch to tirzepatide, or a dual-compound formula may work best when semaglutide plateaus
The break trial represents valuable experiment for any GHK-Cu user completing 6+ month treatment course - discontinuing for 2-3 months reveals how well benefits persist, helps determine whether cycling or continuous use better suits individual biology, provides psychological break from rigid routine, and offers cost savings period while assessing necessity of ongoing application